Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2019-05-30 Investor Presentation
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Further to our intimation dated May 24, 2019 regarding approval of Audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and financial year ended ....
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation May 2019' and is addressed as an intimation of an investor presentation. It contains detailed financial highlights, consolidated profit and loss statements, balance sheets, debt break-ups, and company history. The text explicitly states it is an 'Investor Presentation' and includes forward-looking statements, financial performance metrics, and strategic outlook. The document length is substantial (15,000 characters), indicating it is the full presentation, not just a brief announcement. Therefore, this document fits the category of an Investor Presentation (IP).
2019-05-30 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide ....
Interim / Quarterly Report Classification · 95% confidence The document contains multiple references to "Audited Financial Results for the quarter and financial year ended March 31, 2019," with detailed financial figures such as total income from operations, net profit/loss after tax, earnings per share, and other financial metrics. It mentions compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes signatures from company officials. The document is about the publication of audited financial results for a full fiscal year and quarter, with detailed financial data presented. This matches the characteristics of an Interim / Quarterly Report (IR) because it includes quarterly and year-end audited financial results with substantive financial data and analysis. It is not a short announcement or a certification letter but a detailed financial disclosure. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2019-05-29 English
Pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 and further to our intimation dated April 16, 2019 regarding 'a planned ....
Regulatory Filings Classification · 95% confidence The document is an intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015, regarding the completion of maintenance work and a de-bottlenecking programme at a subsidiary's plant. It includes a press release announcing the completion of the maintenance and capacity expansion. The document is a regulatory announcement informing the stock exchange and investors about operational updates, not a financial report or detailed presentation. It does not contain financial statements, management discussion, or detailed financial data. The document is relatively short (5713 characters) and serves as a formal notification of an operational update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-05-29 English
Further to our intimation dated May 24, 2019 regarding approval of Audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and financial year ....
Earnings Release Classification · 100% confidence The document is titled 'Earnings Release' and contains detailed financial performance data for the fiscal year ended March 31, 2019, including revenue, EBITDA, PAT, and margin percentages. It also includes commentary from the Managing Director, business updates, awards, and credit rating information. The document is over 10,000 characters long, indicating it is a full release rather than a brief announcement. The text explicitly states it is an Earnings Release dated May 24, 2019, and references the approval of audited financial results by the Board of Directors. There is no indication that this is a full Annual Report (10-K) or an Interim Report (IR), nor is it a simple announcement or certification. Therefore, the document fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights. FY 2019
2019-05-24 English
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period ....
Regulatory Filings Classification · 95% confidence The document is titled 'Secretarial Compliance Report for the year ended March 31, 2019' and is certified by a company secretary firm. It references compliance with SEBI regulations and various securities laws. The document is a compliance certification report rather than a full annual report or financial statement. It is a regulatory compliance attestation, not containing financial data or management discussion. The document length is 4271 characters, which is relatively short and consistent with a compliance report. This type of document fits best under Regulatory Filings (RNS) as it is a compliance report and certification rather than a full financial or management report.
2019-05-24 English
Dil Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2019, inter alia, have recommended final equity dividend @ Rs. 1.25/- per equity share ....
Annual Report Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) reporting the outcome of a Board Meeting held on May 24, 2019. It specifically mentions approval of the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2019, as per SEBI Listing Regulations. The letter also encloses the Auditors' Reports and a statement on audit qualifications. Additionally, it mentions a recommended final equity dividend for the financial year ended March 31, 2019. The document contains detailed financial tables with quarterly and annual audited results, including revenue, expenses, profit/loss, and comprehensive income figures. This indicates it is a comprehensive financial report for the full fiscal year, not just a brief announcement or a certification. The presence of full audited financial results and auditor's report aligns with the characteristics of an Annual Report (10-K equivalent). It is not merely an announcement or a certification, nor is it a short earnings release or interim report. Therefore, the document should be classified as an Annual Report (10-K).
2019-05-24 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.